@article{4b33ea79b0fe4e21aa73445d9f649b8e,
title = "Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: Report of a randomized study. Diabetes care 2018;41:1275–1284",
author = "Hiroshi Itoh and Kenji Ueshima and Issei Komuro",
note = "Funding Information: Acknowledgments. EDIT, Inc. (Tokyo, Japan) provided medical writing and editing. Funding and Duality of Interest. The EMPATHY study was supported by Shionogi & Co., Ltd. H.I. reports grants and personal fees from Shionogi & Co., Ltd. during the conduct of the study and grants and personal fees from Takeda Pharmaceutical Company Limited, Nippon Boehringer Ingelheim Co., Ltd., Daiichi Sankyo Company, Limited, MSD K.K., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Ltd., and Taisho Toyama Pharmaceutical Co., Ltd.; grants from Sumitomo Dainippon Pharma Co., Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Co., Ltd., Teijin Pharma Limited, Mo-chida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Eli Lilly Japan K.K.; and personal fees from Nipro Corporation and SBI Pharmaceuticals Co., Ltd. outside the submitted work. K.U. reports other (contracted work) from Shionogi & Co., Ltd. during the conduct of the study and personal fees from Shionogi & Co., Ltd. outside the submitted work. I.K. reports personal fees from Shionogi & Co., Ltd. during the conduct of the study and grants and",
year = "2018",
month = nov,
day = "1",
doi = "10.2337/dci18-0028",
language = "English",
volume = "41",
pages = "e145--e146",
journal = "Diabetes care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "11",
}
